A person affected by this disease has to follow a low-protein diet all his life. Otherwise, phenylalanine will accumulate in the body and can lead to severe damage to the central nervous system.
As the cell's protein factory, the ribosome is the only natural machine that manufactures its own parts. That is why understanding how the machine, itself, is made, could unlock the door to everything from understanding how life develops to designing new methods of drug production.
If an unconscious person responds to smell through a slight change in their nasal airflow pattern -- they are likely to regain consciousness. This is the conclusion from a new study conducted by Weizmann Institute scientists and colleagues at the Loewenstein Rehabilitation Hospital, Israel.
A group of Hokkaido University researchers has developed a paper-based device that can easily and cheaply measure lithium ion concentration in blood, which could greatly help bipolar disorder patients.
An international multicenter study describes a rare disease characterized by a series of recognizable facial features, cardiac defects and intellectual disability, which they propose to name as TRAF7 syndrome -- according to the name of the gene that causes this pathology.
While it's too soon to use COVID-19 antibody testing to issue 'immunity passports', antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.
Technology may lead to rapid diagnosis based on CT scans and patient data.
Researchers developed a method using fluorescence to detect precancerous metabolic and physical changes in individual epithelial cells lining the cervix, and can visualize those changes at different depths of the epithelial tissue near the surface. The method, which can detect precancerous lesions non-invasively and non-destructively, opens the door to early-stage bedside diagnostics.
Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that the lesions are malignant, according to a new study.
What if doctors could not only diagnose a COVID-19 infection but identify which patients are at the greatest risk of death before any major complications arise? One Michigan State University scientist believes nanotechnology may be the answer.